GC CELL CORPORATION
Cell and gene therapy specialist with integrated CDMO, bio-logistics, and cell banking.
144510 | KO
Overview
Corporate Details
- ISIN(s):
- KR7144510005
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 이현로30번길 107, 용인시
- Website:
- http://gccell.com/en/main.do
- Sector:
- Manufacturing
Description
GC CELL CORPORATION specializes in cell and gene therapy, providing a fully integrated value chain from research to commercialization. The company's core offerings include end-to-end Contract Development and Manufacturing Organization (CDMO) services for autologous and allogeneic cell therapies, comprehensive bio-logistics, and cell banking. Its integrated model supports partners throughout the entire drug life cycle, from initial development and manufacturing to clinical trials and commercial distribution. In addition to its service-based solutions, GC CELL develops proprietary cell therapy products, including Immuncell-LC, an adjuvant therapy for hepatocellular carcinoma. The company focuses on advancing treatments in areas such as immune-oncology and delivering customized solutions to enhance patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-08-25 00:00 |
주주총회소집공고
|
Korean | 265.2 KB | ||
| 2021-08-23 00:00 |
투자판단관련주요경영사항(급성호흡곤란증후군 환자를 대상으로 CT303(동종편도유래중간엽줄기세포)의 단회투여 시 안전성, 내약성 및 유효성 평가를…
|
Korean | 9.3 KB | ||
| 2021-08-23 00:00 |
의결권대리행사권유참고서류
|
Korean | 189.5 KB | ||
| 2021-08-19 00:00 |
투자판단관련주요경영사항(중등도에서 중증 판상형 건선 환자를 대상으로 CT303(동종편도유래중간엽줄기세포)의 단회투여 및 반복투여 시 안전성, …
|
Korean | 10.0 KB | ||
| 2021-08-19 00:00 |
[기재정정]투자판단관련주요경영사항(중등도에서 중증 판상형 건선 환자를 대상으로 CT303(동종편도유래중간엽줄기세포)의 단회투여 및 반복투여 시…
|
Korean | 13.8 KB | ||
| 2021-08-13 00:00 |
[기재정정]주요사항보고서(회사합병결정)
|
Korean | 46.9 KB | ||
| 2021-08-13 00:00 |
[기재정정]증권신고서(합병)
|
Korean | 3.8 MB | ||
| 2021-08-12 00:00 |
[기재정정]주주총회소집결의
|
Korean | 22.6 KB | ||
| 2021-08-12 00:00 |
[기재정정]주요사항보고서(회사합병결정)
|
Korean | 51.3 KB | ||
| 2021-08-12 00:00 |
[기재정정]증권신고서(합병)
|
Korean | 4.8 MB | ||
| 2021-08-11 00:00 |
투자설명서
|
Korean | 3.3 MB | ||
| 2021-08-11 00:00 |
반기보고서 (2021.06)
|
Korean | 1.4 MB | ||
| 2021-07-30 00:00 |
[기재정정]주요사항보고서(회사합병결정)
|
Korean | 47.6 KB | ||
| 2021-07-30 00:00 |
[기재정정]증권신고서(합병)
|
Korean | 3.4 MB | ||
| 2021-07-27 00:00 |
[기재정정]주요사항보고서(회사합병결정)
|
Korean | 48.0 KB |
Automate Your Workflow. Get a real-time feed of all GC CELL CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GC CELL CORPORATION
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GC CELL CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
